CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of GBP 44.40 billion. The enterprise value is 102.61 billion.
Market Cap | 44.40B |
Enterprise Value | 102.61B |
Important Dates
The next estimated earnings date is Wednesday, February 12, 2025.
Earnings Date | Feb 12, 2025 |
Ex-Dividend Date | Oct 21, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.08% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 11.86.
PE Ratio | 11.86 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.49, with an EV/FCF ratio of 81.52.
EV / Earnings | 27.42 |
EV / Sales | 0.35 |
EV / EBITDA | 7.49 |
EV / EBIT | 13.54 |
EV / FCF | 81.52 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.10.
Current Ratio | 0.80 |
Quick Ratio | 0.54 |
Debt / Equity | 1.10 |
Debt / EBITDA | 4.80 |
Debt / FCF | 49.02 |
Interest Coverage | 3.30 |
Financial Efficiency
Return on equity (ROE) is 6.70% and return on invested capital (ROIC) is 3.81%.
Return on Equity (ROE) | 6.70% |
Return on Assets (ROA) | 2.37% |
Return on Capital (ROIC) | 3.81% |
Revenue Per Employee | 1.06M |
Profits Per Employee | 14,422 |
Employee Count | 300,000 |
Asset Turnover | 1.46 |
Inventory Turnover | 17.78 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.30% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -41.30% |
50-Day Moving Average | 56.33 |
200-Day Moving Average | 60.81 |
Relative Strength Index (RSI) | 24.34 |
Average Volume (20 Days) | 19,182 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.29 |
Income Statement
In the last 12 months, CVS Health had revenue of GBP 274.00 billion and earned 3.74 billion in profits. Earnings per share was 2.95.
Revenue | 274.00B |
Gross Profit | 37.84B |
Operating Income | 7.11B |
Pretax Income | 5.02B |
Net Income | 3.74B |
EBITDA | 10.53B |
EBIT | 7.11B |
Earnings Per Share (EPS) | 2.95 |
Balance Sheet
The company has 7.22 billion in cash and 61.71 billion in debt, giving a net cash position of -54.48 billion.
Cash & Cash Equivalents | 7.22B |
Total Debt | 61.71B |
Net Cash | -54.48B |
Net Cash Per Share | n/a |
Equity (Book Value) | 56.04B |
Book Value Per Share | 44.45 |
Working Capital | -12.90B |
Cash Flow
In the last 12 months, operating cash flow was 3.44 billion and capital expenditures -2.18 billion, giving a free cash flow of 1.26 billion.
Operating Cash Flow | 3.44B |
Capital Expenditures | -2.18B |
Free Cash Flow | 1.26B |
FCF Per Share | n/a |
Margins
Gross margin is 13.81%, with operating and profit margins of 2.60% and 1.37%.
Gross Margin | 13.81% |
Operating Margin | 2.60% |
Pretax Margin | 1.83% |
Profit Margin | 1.37% |
EBITDA Margin | 3.84% |
EBIT Margin | 2.60% |
FCF Margin | 0.46% |
Dividends & Yields
This stock pays an annual dividend of 2.09, which amounts to a dividend yield of 4.71%.
Dividend Per Share | 2.09 |
Dividend Yield | 4.71% |
Dividend Growth (YoY) | 7.36% |
Years of Dividend Growth | 2 |
Payout Ratio | 66.07% |
Buyback Yield | 2.08% |
Shareholder Yield | 6.79% |
Earnings Yield | 8.45% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CVS Health has an Altman Z-Score of 2.13. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.13 |
Piotroski F-Score | n/a |